A PHASE II TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) CONCOMITANT WITH RADIOSURGERY FOR THE TREATMENT OF RECURRENT, BEVACIZUMAB-NAIVE GLIOBLASTOMA

被引：0
|
作者：
Harat, Maciej [1 ]
Blok, Maciej [2 ]
Adamczak-Sobczak, Magda [2 ]
Szymanski, Pawel [2 ]
Miechowicz, Iza [3 ]
Malkowski, Bogdan [1 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Med, Bydgoszcz, Poland
[2] Prof Franciszek Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[3] Poznan Univ Med Sci, Poznan, Poland
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-46
引用
收藏
页码：52 / 53
页数：3
相关论文
共 50 条
  • [31] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Pierscianek, Daniela
    Guberina, Nika
    Kleinschnitz, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 61 - 61
  • [32] Tumor Treating Fields (TTFields) Concomitant with PARP Inhibitors for Treatment of Ovarian Cancer Cell Lines
    Martinez-Conde, A.
    Frechtel-Gerzi, R.
    Ene, H.
    Dor-On, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E276 - E276
  • [33] Underlining mechanism for the efficacy of tumor treating fields (TTFields) concomitant with sorafenib for treatment of hepatocellular carcinoma
    Davidi, S.
    Jacobovitch, S.
    Shteingauz, A.
    Tempel-Brami, C.
    Munster, M.
    Zeevi, E.
    Dor-On, E.
    Schneiderman, R.
    Voloshin, T.
    Haber, A.
    Giladi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S162 - S163
  • [34] Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
    Frechtel-Gerzi, Roni
    Gerasimova, Daria
    Zeevi, Einav
    Schlachet-Drukerman, Inbar
    Mumblat, Helena
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Palmer, Greg
    Secord, Angeles A.
    CANCER RESEARCH, 2023, 83 (07)
  • [35] EF-32 (TRIDENT): A pivotal phase 3 randomized trial of concomitant radiation therapy and temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma
    Glas, M.
    Kleinberg, L.
    Jeyapalan, S.
    Goldlust, S.
    Nagpal, S.
    Combs, S.
    Roberge, D.
    Nishikawa, R.
    Reardon, D.
    Grossman, R.
    Shi, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S97 - S98
  • [36] Phase II HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma
    Grosu, Anca
    Gkika, Eleni
    Brunner, Thomas B.
    Thimme, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [37] HEPANOVA: A phase II trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma
    Grosu, Anca-Ligia
    Strouthos, Josif
    Brunner, Thomas
    Weinberg, Uri
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Phase II trial of bevacizumab and erlotinib in recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, Sith
    Vredenburgh, James
    Rich, Jeremy
    Desjardins, Annick
    Quinn, Jennifer
    Bota, Daniela
    Goli, Krishna
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [39] Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment
    Wang, Minjie
    Zhang, Chaocai
    Wang, Xuan
    Yu, Hao
    Zhang, Hemei
    Xu, Junnv
    Zhao, Jiannong
    Jiang, Xiaobing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (04): : 1069 - 1086
  • [40] Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
    Kreisl, Teri N.
    Kim, Lyndon
    Moore, Kraig
    Duic, Paul
    Royce, Cheryl
    Stroud, Irene
    Garren, Nancy
    Mackey, Megan
    Butman, John A.
    Camphausen, Kevin
    Park, John
    Albert, Paul S.
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 740 - 745
12345